Eyes On Tomorrow
🎧 Dry Eye Disease is changing – are you keeping up?
From the game-changing new definition of DED — where patient symptoms truly matter — to why blue light therapy is now a core part of care, Sarah cuts through the noise with insights you can apply immediately.
In this episode, we explore:
✨ The emerging evidence around Demodex as a bacterial “vehicle”
✨ The growing role of systemic inflammation in DED
✨ Why meibomian gland imaging can reveal disease up to 10 years before symptoms appear
If you’re serious about earlier detection, better outcomes, and smarter clinical decisions, this is a must-listen.
Eyes on tomorrow is supported by Topcon Healthcare and Thea UK. Produced by Matt Hill at Rethink Audio.
Listen on Apple Podcasts: